HeartBeam Inc. Secures Two New U.S. Patents for Innovative Cardiac Technology

HeartBeam Inc. (NASDAQ: BEAT) has recently achieved a significant advancement in cardiac technology with the granting of two new U.S. patents. These patents are a testament to the company's ongoing innovation in the field of heart health monitoring, particularly through its proprietary 3D ECG platform. The first patent introduces a credit card-sized, cable-free 3D ECG device, a portable solution designed to capture high-fidelity electrical signals from the heart in three noncoplanar directions. This device, utilizing chest and finger electrodes, represents a significant step forward in making cardiac monitoring more accessible and convenient for patients. More information about this innovative device can be found here.

The second patent focuses on HeartBeam's rhythm analysis algorithm, a technology that continuously analyzes signal input to offer real-time insights into heart health. This algorithm is pivotal for the early detection of arrhythmias and other cardiac conditions, enabling timely interventions that could save lives. Together, these patents not only expand HeartBeam's intellectual property portfolio but also reinforce its commitment to revolutionizing cardiac care through technology that is both powerful and patient-friendly. The implications of these advancements are profound, promising more accurate, efficient, and accessible heart health monitoring solutions globally. For those interested in tracking HeartBeam's progress, updates are available in the company's newsroom at https://ibn.fm/BEAT.